Enhancing bispecific antibody therapies with healthy donor T cells

Research unit

INNOSUISSE

Project number

61834.1 IP-LS

Project title

Enhancing bispecific antibody therapies with healthy donor T cells (Innolink: 100.763 IP-LS)

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	Enhancing bispecific antibody therapies with healthy donor T cells (Innolink: 100.763 IP-LS)
Short description (English)	Enhancing bispecific antibody therapies with healthy donor T cells
Abstract (German)	Bispecific antibodies (biAbs) rely on autologous T cells which, in cancer patients, are often insufficient. Encelta has developed Allogeneic-Engineered-Decoupled (AED) T cells from healthy donors that can be used safely (no GvHD) and effectively against tumor cells when activated with a biAb.